Stock TNXP TONIX PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Tonix Pharmaceuticals Nasdaq

Equities

TNXP

US8902608624

End-of-day quote Nasdaq
Other stock markets
 23:00:00 04/02/2024 GMT 		5-day change 1st Jan Change
0.3222 USD -2.36% Intraday chart for Tonix Pharmaceuticals +2.32% -20.05%
06-27 Top Midday Decliners MT
06-27 Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Midday Decliners
MT
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data
MT
Top Premarket Decliners
MT
Tonix Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule
MT
Tonix Pharmaceuticals Holding Corp. Presents Vaccine Platform Data in Keynote Talk At the Vaccine Congress 2024
CI
Tonix Pharmaceuticals Holding Corp. Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya for the Management of Fibromyalgia
CI
Top Midday Decliners
MT
Wall Street Set to Open Higher Wednesday as Key Inflation Data Lower Than Expected
MT
US Futures Slightly Higher Ahead of Fed's Rate Decision, Key Inflation Data
MT
Top Premarket Decliners
MT
Tonix Pharmaceuticals Plans Common Stock Offering to Fund New Drug Application for Fibromyalgia; Shares Fall After Hours
MT
Reverse Split: 1 of 32
FA
Reverse Split: 1 of 32
FA
Tonix Pharmaceuticals to Implement 1-for-32 Reverse Stock Split -- Shares Fall
MT
Tonix Pharmaceuticals Holding Corp. Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500
CI
ToniTonix Pharmaceuticals Holding Corp. Presents New Data on Tonmya Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
CI
Tranche Update on Tonix Pharmaceuticals Holding Corp.'s Equity Buyback Plan announced on January 25, 2023.
CI
Tonix Pharmaceuticals Holding Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Tonix Pharmaceuticals Holding Corp.'s Equity Buyback Plan announced on January 25, 2023.
CI
Tonix Pharmaceuticals Holding Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TNXP Stock
  4. TNXP Stock
  5. News Tonix Pharmaceuticals
  6. Highlights